Environmental Risk Assessment of Pharmaceuticals - Effects on Fish in a Swedish River

Purpose The aim of this study was to assess exposure and chronic effects on fish from down- the-drain pharmaceuticals in the Swedish Göta Älv river. Both effects of individual pharmaceuticals and mixture effects were evaluated.Methods Spatially resolved exposure of pharmaceuticals was modelled with...

Full description

Bibliographic Details
Main Authors: Furberg, Anna, Arvidsson, Rickard, Florberger, Maria, Molander, Sverker
Language:unknown
Published: 2014
Subjects:
Online Access:https://research.chalmers.se/en/publication/208022
Description
Summary:Purpose The aim of this study was to assess exposure and chronic effects on fish from down- the-drain pharmaceuticals in the Swedish Göta Älv river. Both effects of individual pharmaceuticals and mixture effects were evaluated.Methods Spatially resolved exposure of pharmaceuticals was modelled with the Geo- referenced Regional Environmental Assessment Tool for European Rivers (GREAT-ER) and mixture effects were calculated using the concept of concentration addition as a conservative first tier. A habitat comparison was performed by comparing the locations with high concentrations of pharmaceuticals to the locations of known habitats in the Göta Älv river for the fish Salmo salar and Salmo trutta. The modelling results were also validated by comparison with measurements of concentrations performed in other Swedish rivers. In total, 12 pharmaceuticals were studied; diclofenac, propranolol, carbamazepine, ethinylestradiol, ibuprofen, metoprolol, gemfibrozil, estradiol, paracetamol, sertraline, verapamil and estrone.Results and discussion The results of the modelling showed that the predicted pharmaceutical concentrations in the Göta Älv river, when considered individually, generally did not cause adverse chronic effects to fish. An exception was gemfibrozil, which may cause adverse chronic effects to fish in some parts of the river. However, when mixture effects were considered, the results showed that adverse chronic effects might occur in parts of the river. The risk ratios for the mixture were relatively high (between 0.61 and 0.81) in almost all parts of the river. The two parts of the Göta Älv river catchment with the highest concentrations of the studied pharmaceuticals, were also the parts with known habitats for the studied fish species. The validation of the modelling results showed that the predicted pharmaceutical concentrations in the Göta Älv river were much lower than measured concentrations in other Swedish waters. The reasons for this were probably the large difference in both the number of people ...